Navigation Links
Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation
Date:9/1/2014

(PRWEB) September 01, 2014

Parties involved in federally-filed Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) are looking ahead to the litigation’s status conference in September, where issues related to claims involving the pain reliever will be discussed in the Eastern District of Pennsylvania, Bernstein Liebhard LLP reports.

According to a schedule of status conferences posted on the Court’s website, the meeting is scheduled to take place on September 16th, 2014 at 10:00 a.m. This is the latest of several Tylenol conferences that have taken place this year in the U.S. District Court, Eastern District of Pennsylvania, where dozens of lawsuits have been filed against Johnson & Johnson and McNeil Consumer Healthcare. Plaintiffs in Tylenol claims allege serious liver damage caused by the medication’s active ingredient, acetaminophen. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“We are looking forward to the Tylenol litigation’s September status conference, as we are speaking on a regular basis with individuals who sustained liver damage allegedly caused by the pain relieving medication,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Tylenol. The Firm is offering free legal reviews to individuals who allegedly suffered acetaminophen-related liver damage that resulted in hospitalization, liver transplantation, or death.

Tylenol Lawsuits Alleging Liver Damage

According to a federal Case List updated on August 15th, at least 154 Tylenol lawsuits are now pending in the federal litigation underway in the Eastern District of Pennsylvania. These claims involve alleged instances where individuals took the medications and were hospitalized, needed a liver transplant or even died after taking the medication in accordance with label directions.

A Philadelphia Inquirer report from earlier this year calls attention to the dangers associated with acetaminophen. According to the article published in February 2014, toxic reactions related to the Tylenol ingredient result in 78,000 emergency room visits and 33,000 hospitalizations.*

In August 2013, Bloomberg.com reported that acetaminophen contained in certain over the-counter Tylenol products exceeded the amount limited by the U.S. Food and Drug Administration (FDA) two years earlier for prescription drugs. The federal agency announced in 2011 that these medications were not to contain more than 325 mg of acetaminophen per tablet, but placed no such cap on over-the-counter products. Extra Strength Tylenol tablets each contain 500 mg of the ingredient, according to Bloomberg.**

Individuals who allegedly sustained serious liver damage after taking Tylenol may be eligible to receive compensation for injury-related damages. Learn more about filing a Tylenol lawsuit when you visit Bernstein Liebhard LLP’s website, or call the following number for a free legal review: 800-511-5092.

*articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/tylenol-lawsuit/tylenol-liver-damage/prweb12132602.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Comments on New Analysis Questioning Labeling Standards for Over-The-Counter Acetaminophen Products
2. Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Tylenol Liver Damage Litigation
3. Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports
4. As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen
5. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
6. As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Finding that Acetaminophen Combined With Alcohol May Increase Risk for Kidney Damage
7. Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Release of Study Finding Tylenol Use in Pregnancy May Affect Child Development
8. Tylenol Liver Problem Allegations Help: Resource4thePeople Comments on Legal Developments
9. Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Tylenol Litigation
10. Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Claim Alleging Use of Tylenol Caused Liver Damage
11. Tylenol Liver Damage Allegations Lawyer Help: Resource4thePeople Reports Judge Outlines Procedures for Bellwether Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... and Shelton, CT (PRWEB) , ... May 02, 2016 , ... ... President and Owner of New England Low Vision and Blindness (NELV&B) , announces ... add more flexibility and convenience for people with vision impairments to get assessments, hands-on ...
(Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology: